NEKTAR THERAPEUTICS shareholders Q3 2023

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.

NEKTAR THERAPEUTICS shareholders Q3 2023
NameSharesValueWeighting ↓
Freestone Capital Holdings, LLC 20,000$11,9120.00%
Vanguard Personalized Indexing Management, LLC 38,584$22,9810.00%
FRANKLIN STREET ADVISORS INC /NC 15,500$90.00%
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 310,124$185,0000.00%
Schonfeld Strategic Advisors LLC 119,200$70,9950.00%
FIRST CITIZENS BANK & TRUST CO 51,311$30,5600.00%
China Universal Asset Management Co., Ltd. 4,880$30.00%
SG Americas Securities, LLC 77,858$460.00%
Citadel Advisors 5,625,000$3,350,2500.00%
Salomon & Ludwin, LLC 46$270.00%
Citadel Advisors 8,100$4,8240.00%
Citadel Advisors 46,800$27,8740.00%
ATLAS CAPITAL ADVISORS LLC 600$3570.00%
HRT FINANCIAL LP 34,167$200.00%
Daiwa Securities Group Inc. 539$00.00%
Steward Partners Investment Advisory, LLC 200$1190.00%
Qube Research & Technologies Ltd 57,528$34,2640.00%
Versant Capital Management, Inc 752$4480.00%
FARMERS & MERCHANTS INVESTMENTS INC 113$670.00%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 61,886$370.00%
External links

This page lists NEKTAR THERAPEUTICS's shareholders in Q3 2023. To view NEKTAR THERAPEUTICS's shareholder history, click here.